Sterling Investment Advisors (Pennsylvania)’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,500
| Closed | -$1K | – | 570 |
|
|
2022
Q2 | $1K | Hold |
2,500
| – | – | ﹤0.01% | 544 |
|
|
2022
Q1 | $3K | Hold |
2,500
| – | – | ﹤0.01% | 529 |
|
|
2021
Q4 | $3K | Hold |
2,500
| – | – | ﹤0.01% | 525 |
|
|
2021
Q3 | $5K | Hold |
2,500
| – | – | ﹤0.01% | 486 |
|
|
2021
Q2 | $4K | Hold |
2,500
| – | – | ﹤0.01% | 477 |
|
|
2021
Q1 | $6K | Hold |
2,500
| – | – | ﹤0.01% | 440 |
|
|
2020
Q4 | $6K | Hold |
2,500
| – | – | ﹤0.01% | 401 |
|
|
2020
Q3 | $6K | Hold |
2,500
| – | – | ﹤0.01% | 373 |
|
|
2020
Q2 | $8K | Hold |
2,500
| – | – | ﹤0.01% | 362 |
|
|
2020
Q1 | $5K | Hold |
2,500
| – | – | ﹤0.01% | 350 |
|
|
2019
Q4 | $5K | Hold |
2,500
| – | – | ﹤0.01% | 370 |
|
|
2019
Q3 | $5K | Hold |
2,500
| – | – | ﹤0.01% | 373 |
|
|
2019
Q2 | $4K | Hold |
2,500
| – | – | ﹤0.01% | 383 |
|
|
2019
Q1 | $5K | Hold |
2,500
| – | – | ﹤0.01% | 372 |
|
|
2018
Q4 | $3K | Hold |
2,500
| – | – | ﹤0.01% | 375 |
|
|
2018
Q3 | $6K | Hold |
2,500
| – | – | ﹤0.01% | 377 |
|
|
2018
Q2 | $8K | Hold |
2,500
| – | – | ﹤0.01% | 339 |
|
|
2018
Q1 | $11K | Buy |
+2,500
| New | +$11K | 0.01% | 314 |
|